Cancer is a disease that breaks the hearts of every single person, altering the lives of many. And, we think it is safe to say that everybody wants nothing more than those who are heartbreakingly diagnosed with cancer to be able to say they beat it.
Well, a huge breakthrough has been reached for those diagnosed with colorectal cancer, found in the colon, or the rectum.
The breakthrough comes as a small cancer drug trial has sent all of its patience into remission.
According to Cancer.net, colorectal cancer is the third most diagnosed type of cancer in both men and women in the United States. And in 2022 alone, it is estimated that 151,030 adults will be diagnosed with the disease.
It’s not only the third most diagnosed cancer in the US but worldwide, too. In 2020, 1,880,725 people were diagnosed with colorectal cancer.
And that’s why upon testing Dostarlimab, a cancer drug that acts as a substitute antibody in the human body, both doctors and cancer patients have been left over the moon as it appeared those who participated in the trial had moved into remission one year after the trial.
In total, there were eighteen colorectal cancer patients who participated in the trial, and all eighteen patients were cancer-free, as per LADbible.
Dr. Luis A. Diaz Jr. who works at New York’s Memorial Sloan Kettering Cancer Centre emphasized just how important the breakthrough really is, “This is the first time this has happened in the history of cancer,” he said.
Dr. Andrea Cercek, the co-author of the paper containing the findings, which was published in the New England Journal of Medicine, expressed that the patients were overjoyed.
“There were a lot of happy tears,” she said.
But, this isn’t the only drug that has been bringing tears of joy to patients who have been diagnosed with cancer.
Because a drug called vaxinia has also proven to be successful. First tested on animals, and now, tested on its first-ever human, it has been found to shrink the size of cancer.
It seems as though science is finally making a whole wave of breakthroughs in the world of cancer research.
What do you think about the news?